The Journal of Precision Medicine - The Rise of Predictive Genomics

Cytox White Paper - The clinical application of polygenic risk assessment to reduce the risk of cognitive decline in subjects with early cognitive concerns

Progress in Neurology and Psychiatry - video series on clinical application of polygenic risk scoring in Alzheimer's disease

Video Journal of Neurology - Richard Pither interview on genetic testing for Alzheimer's Disease

DNA Weekly - Early Detection Of Alzheimer's Disease Can Save Your Brain

BioScience Today coverage: Tackling the trillion dollar Alzheimer's disease

MedNous coverage: Genetic risk assessment in Alzheimer's disease

Cytox InfoGraphic - Transforming the future of healthcare by identifying those with highest genetic risk for developing late-onset Alzheimer’s Disease

Cytox White Paper on assessing Alzheimer’s disease risk using polygenic risk scoring biomarkers updated following validation by new study

Cytox White Paper on Assessing Alzheimer’s disease risk using polygenic risk scoring biomarkers

Cytox’s breakthrough polygenic risk scoring approach for assessing Alzheimer’s disease risk poised to accelerate therapeutic targeting. See BioCentury’s report on ‘Diagnosing AD Trials’